Intervention group (TAU + PT + VIT) | Control group (TAU + PT) | |||||
---|---|---|---|---|---|---|
Baseline mean (SD) n = 20 | Mean change (SD) BL to PT n = 17 | Mean change (SD) BL to follow-up n = 16 | Baseline mean (SD) n = 10 | Mean change (SD) BL to PT n = 9 | Mean change (SD) BL to follow-up n = 9 | |
PRF | 2.45 (1.19) | 0 (1.62) | 0.19 (1.67) | 3.6 (1.51) | −0.11 (1.05) | −0.67 (.29)* |
GHQ-12 | 19 (8) | −11.05 (8.14)* | −5.93 (8.59) | 22.1 (6.38) | −9.33 (9.42) | −11.11 (6.07)* |
SDQ | 23.7 (8.68) | −4.88 (5.85)* | −2.25 (5.11) | 25.2(8.31) | −4.67 (4.3)* | −6.78 (6.55) |
SDQ-ext | 12.4 (5.79) | −3.35 (3.2)* | −.88 (3.72) | 13.1 (6.42) | −1.56 (3.68) | −9.22 (4.58)* |
SDQ-int | 11.3 (4.57) | −1.53 (4.89) | −1.38 (3.34) | 12.1 (3.7) | −9.89 (3.37) | −3.44 (3.64)* |
CGAS | 39.85 (15.22) | 21.06 (18.32)*,a | 17.83 (19.42)*,a | 44.8 (7.58) | 16 (11.7)*,b | 14 (19.44)* |